Therapeutic use of 20-kilodalton human growth hormone
US6399565B1 · kind B1 · utility
6Cited by
1References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 1997 |
| Grant date | Jun 4, 2002 |
| Priority date | — |
| Expiry date | Dec 15, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Administration of an administrative amount of an authentic human growth hormone having a molecular weight of 20,000 daltons to human adults can improve body composition, stimulate lipolysis, increase serum insulin-like growth factor I or be used in replacement therapy for human growth hormone-deficient patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.